Neonatal Care Transparency Act of 2025

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. _____/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H H.R. 7973, Momnibus Act; H.R. 7830, WELLS Act; S. 2433, Neonatal Care Transparency Act; S. 3698/H.R. 7227, Mental Health and MAMA Act; H.R. 6468, Rural Residency Planning and Development Act of 2025; H.R.8159, Gynecologic Pain Management Study Act; H.R.8160, Premenstrual Dysphoric Disorder Awareness and Research Act; H.R.7733, Ensuring OB-GYN Care In Prisons Act; H.R.7148, Consolidated Appropriations Act of 2026; S. Res. 590, Maternal Health Awareness Day Resolution; H.R. ____, Prepregnancy Healthcare Awareness Act; H.R. 7841, Warrior Infertility Act; Toxic Substances Control Act (TSCA); maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); funding for providers of reproductive health care (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S.____, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); Maternity Care Target Areas proposed updates; Emergency Medical Treatment and Active Labor Act (EMTALA)

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1 One Big Beautiful Bill Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; S.1882, H.R.3589 RESTORE Act; Shield laws; Chemical abortion drugs; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; H.R. 5485 Second Chance at Life Act of 2025; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; S.2955 A bill to amend title 18, United States Code, to establish Federal penalties for the knowing and intentional administration of any abortion-inducing drug to a woman without her informed consent, if the abortion-inducing drug has been shipped or transported in interstate commerce, and for other purposes; Patient Protection and Affordable Care Act; Abortion funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; Shield Laws; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; Patient Protection and Affordable Care Act; Contraception Issues; National Defense Authorization Act; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; Administration Personnel and Judicial Nominees; Presidential Administration Actions

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office